podophyllotoxin has been researched along with norcantharidin in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Han, HW; Hu, C; Lu, GH; Qi, JL; Qiu, HY; Sun, WX; Wang, XM; Yang, RW; Yang, YH | 1 |
| Bo, YX; Chen, SW; Chen, YZ; Guan, XW; Hui, L; Tang, ZB; Zhao, J | 1 |
2 other study(ies) available for podophyllotoxin and norcantharidin
| Article | Year |
|---|---|
Design, synthesis and anti-cancer activity evaluation of podophyllotoxin-norcantharidin hybrid drugs.
Topics: Antineoplastic Agents; Apoptosis; Bridged Bicyclo Compounds, Heterocyclic; Cell Cycle; Cell Proliferation; Dose-Response Relationship, Drug; Drug Design; Drug Screening Assays, Antitumor; HEK293 Cells; Humans; MCF-7 Cells; Molecular Structure; Podophyllotoxin; Structure-Activity Relationship | 2016 |
Conjugates of podophyllotoxin and norcantharidin as dual inhibitors of topoisomeraseâ…ˇ and protein phosphatase 2A.
Topics: Antineoplastic Agents; Bridged Bicyclo Compounds, Heterocyclic; Cell Division; Cell Line, Tumor; G2 Phase Cell Cycle Checkpoints; Humans; Podophyllotoxin; Protein Phosphatase 2; Structure-Activity Relationship; Topoisomerase II Inhibitors | 2016 |